Interleukin I induction

Bui, T., T. Dykers, S.L. Hu, C.R. Ealtynek, and R.I Ho, Effect of MTP-PE liposomes and interleukin-7 on induction of antibody and cell-mediated immune responses to a recombinant HIV-envelope protein. J Acquir Immune Defic Syndr, 1994. 7(8) 799-806. 

Takei T, Kito H, Du W, Mills I, Sumpio BE. Induction of interleukin-1 alpha and beta gene expression in human keratinocytes exposed to repetitive strain Their role in strain-induced keratinocyte proliferation and morphological change. / Cell Biochem. 1998 69 95-103. 

Vercelli, D., Jabara, H.H., Atai, K.I. and Geha, R.S. (1989b). Induction of human IgE synthesis requires interleukin 4 and T/B cell interactions involving the T cell receptor/CD3 complex and MHC class II antigens. J. Exp. Med. 169, 1295-1307. 

Philip PA, Rea D, Thavasu P, Carmichael J, Stuart NS, et al. 1993. Phase I study of bryostatin 1 assessment of interleukin 6 and tumor necrosis factor alpha induction in vivo. The Cancer Research Cam-paignPhaselCommittee. J. Natl. Cancer Inst. 85 1812-18... 

Tabraue, C., Penate, R.D., Gallardo, G., Hernandez, I., Quintana, J., Blanco, F.L., Reyes, J.G., Fanjul, L.F., and Ruiz De Galarreta, C.M. (1997). Induction of guanosine triphosphate-cyclohydrolase by follicle-stimulating hormone enhances interleukin-1 P-stimulated nitric oxide synthase activity in granulosa cells. Endocrinology 738 162-168. 

A16. Ashida, T., Kubo, K., Kawabata, I., Katagiri, M., Ogimoto, M., and Yakura, H. Signal transduction mechanisms of la induction in B cells by interleukin-4 and immunoglobulin receptors. Cell. Immunol. 126, 233-238 (1990). 

Zaitsu M, Hamasaki Y, Matsuo M, Kukita A, Tsuji K, Miyazaki M, Hayasaki R, Muro E, Yamamoto S, Kobayashi I, IchimaruT, Kohashi O, Miyazaki S New induction of leukotriene A(4) hydrolase by interleukin-4 and interleukin-13 in human polymorphonuclear leukocytes. Blood 2000 96 601-609. 

Buruiana FE, Sola I, Alonso-Coello P. Recombinant human interleukin 10 for induction of remission in Crohn s disease. Cochrane Database Syst Rev 2010 11 CD005109. 

In a preclinical study in rats, semapimod suppressed the induction of cytokine storm by the anticancer cytokine interleukin-2 without reducing its anticancer properties, which allowed larger doses of interleukin-2 to be used [118 ]. However, a subsequent phase I trial in 24 patients with melanomas and renal cancers failed to show an increase in the tolerated dose of interleukin-2. In combination with high-dose interleukin-2, semapimod >25 mg/rn seemed to exacerbate interleukin-2-induced nephrotoxicity, as grade 3-4 rises in creatinine developed in three of six patients at dosages of 25 or 32 mg/m, compared with one of 16 patients at doses under 16 mg/rr. The maximum... 

Velupillai, P and Ham, DA (1994) Oligosaccharide-specific induction in interleukin 10 production by B22+ cells from schistosome-infected mice A mechanism for regulation of CD4-I-T-cell subsets. Proc Natl Acad Sci U S A91, 18-22. 

---